Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sophia Allaf Shahin"'
Autor:
Binh Thanh Vu, Sophia Allaf Shahin, Jonas Croissant, Yevhen Fatieiev, Kotaro Matsumoto, Tan Le-Hoang Doan, Tammy Yik, Shirleen Simargi, Altagracia Conteras, Laura Ratliff, Chiara Mauriello Jimenez, Laurence Raehm, Niveen Khashab, Jean-Olivier Durand, Carlotta Glackin, Fuyuhiko Tamanoi
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Abstract New therapy development is critically needed for ovarian cancer. We used the chicken egg CAM assay to evaluate efficacy of anticancer drug delivery using recently developed biodegradable PMO (periodic mesoporous organosilica) nanoparticles.
Externí odkaz:
https://doaj.org/article/849a54837dce44fab69e9ca907705965
Autor:
Altagracia Contreras, Carlotta A. Glackin, Shirleen I. Simargi, Juli Unternaehrer, Ruining Wang, Fuyuhiko Tamanoi, Wei Wen, Sophia Allaf Shahin, Liliana Parra Echavarria, Thanh H. Dellinger, Louise Qu, Jeffrey I. Zink
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 14:1381-1394
TWIST protein is critical to development and is activated in many cancers. TWIST regulates epithelial-mesenchymal transition, and is linked to angiogenesis, metastasis, cancer stem cell phenotype, and drug resistance. The majority of epithelial ovari
Autor:
Jonas G. Croissant, Altagracia Conteras, Laurence Raehm, Tammy Yik, Kotaro Matsumoto, Fuyuhiko Tamanoi, Niveen M. Khashab, Laura E. Ratliff, Tan Le Hoang Doan, Carlotta A. Glackin, Yevhen Fatieiev, Shirleen I. Simargi, Chiara Mauriello Jimenez, Sophia Allaf Shahin, Binh Thanh Vu, Jean-Olivier Durand
Publikováno v:
Scientific reports, vol 8, iss 1
Scientific Reports
Scientific Reports, Nature Publishing Group, 2018, 8 (1), pp.8524. 〈10.1038/s41598-018-25573-8〉
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports, Nature Publishing Group, 2018, 8 (1), pp.8524. ⟨10.1038/s41598-018-25573-8⟩
Scientific Reports
Scientific Reports, Nature Publishing Group, 2018, 8 (1), pp.8524. 〈10.1038/s41598-018-25573-8〉
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports, Nature Publishing Group, 2018, 8 (1), pp.8524. ⟨10.1038/s41598-018-25573-8⟩
New therapy development is critically needed for ovarian cancer. We used the chicken egg CAM assay to evaluate efficacy of anticancer drug delivery using recently developed biodegradable PMO (periodic mesoporous organosilica) nanoparticles. Human ova
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199644e63fd98353d1ae43b8569835e7
https://escholarship.org/uc/item/5m17k78n
https://escholarship.org/uc/item/5m17k78n
Autor:
Carlotta A. Glackin, María Vallet-Regí, Sandra Sánchez-Salcedo, Sophia Allaf Shahin, Jeffrey I. Zink
Publikováno v:
E-Prints Complutense. Archivo Institucional de la UCM
instname
E-Prints Complutense: Archivo Institucional de la UCM
Universidad Complutense de Madrid
Chemical Engineering Journal
instname
E-Prints Complutense: Archivo Institucional de la UCM
Universidad Complutense de Madrid
Chemical Engineering Journal
Mesoporous silica nanoparticles (MSNPs) have many potential applications in biomedical fields. However, when MSNPs are exposed to plasma, protein adsorption leads to opsonization and decreases blood circulation time. A new multifunctional nanodevice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebaf2afe2f399b877fcf626634c9cdd3
Autor:
James Finlay, Thanh H. Dellinger, Carlotta A. Glackin, Wei Wen, Fuyuhiko Tamanoi, Jeffrey I. Zink, Ruining Wang, Juyao Dong, Cai M. Roberts, Sophia Allaf Shahin
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine, vol 13, iss 3
Nanomedicine
Nanomedicine
Epithelial ovarian cancer (EOC) is the most deadly gynecologic malignancy on account of its late stage at diagnosis and frequency of drug resistant recurrences. Novel therapies to overcome these barriers are urgently needed. TWIST is a developmental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8edfbf7dd0144a73eda02ef41050d053
https://escholarship.org/uc/item/6mj02610
https://escholarship.org/uc/item/6mj02610
Autor:
Carlotta A. Glackin, Thanh H. Dellinger, John C. Williams, Cai M. Roberts, Sophia Allaf Shahin, Joana Loeza
Publikováno v:
BMC Cancer
Background Most cancer deaths result from tumor cells that have metastasized beyond their tissue of origin, or have developed drug resistance. Across many cancer types, patients with advanced stage disease would benefit from a novel therapy preventin
Autor:
Ruining Wang, Laura E. Ratliff, Carlotta A. Glackin, Sophia Allaf Shahin, Fuyuhiko Tamanoi, Shirleen I. Simargi, Jeffrey I. Zink, Thanh H. Dellinger, Altagracia Contreras, Binh Vu, Julia Unternaehrer-Hamm
Publikováno v:
Cancer Research. 78:2152-2152
Purpose: To develop rapidly operational CAM-PDX (chorioallantoic membrane-patient derived xenograft) tumor models that morphologically resemble human tumors in order to perform therapeutic/efficacy studies targeting TWIST, a transcription factor expr
Autor:
Sophia Allaf Shahin, Emily Ye, Leslie Cisneros, Joana Loeza, Thanh H. Dellinger, James Finlay, Michelle A. Tran, Carlotta A. Glackin, Cai Roberts
Publikováno v:
Clinical Cancer Research. 22:A42-A42
Introduction: Epithelial ovarian cancer (EOC) is particularly deadly due to its fast rate of growth, dissemination, and chemoresistant recurrences. Novel therapies are urgently needed to limit metastasis and restore platinum sensitivity. We have inve